Evaluation of the German biographic screening interview for fetal alcohol spectrum disorder (BSI-FASD).
Adult
Alcohol Drinking
/ adverse effects
Attention Deficit Disorder with Hyperactivity
/ chemically induced
Child
Cohort Studies
Ethanol
/ adverse effects
Female
Fetal Alcohol Spectrum Disorders
/ epidemiology
Germany
/ epidemiology
Humans
Male
Mass Screening
Pregnancy
Prenatal Exposure Delayed Effects
/ chemically induced
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 03 2021
04 03 2021
Historique:
received:
11
04
2020
accepted:
10
02
2021
entrez:
5
3
2021
pubmed:
6
3
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Alcohol consumption during pregnancy may lead to permanent damage in the offspring, including fetal alcohol spectrum disorders (FASD), which have an estimated prevalence of 1-8% worldwide. In adulthood, diagnosing FASD is time-consuming and costly. This study aimed to evaluate the discriminatory power of a German screening instrument for FASD in adults-the biographic screening interview (BSI-FASD). In an open-label comparative cohort study wherein a one-time survey was administered per participant, we compared 22 subjects with confirmed FASD with control groups of 15 subjects diagnosed with attention deficit hyperactivity disorder (ADHD), 20 subjects with alcohol or opiate dependence, 18 subjects with depression, and 31 controls without prenatal alcohol exposure. The BSI-FASD was found to be resource-efficient, user-friendly, comprehensible, and easily applicable. It provided an overall good convergent and discriminant validity with a sensitivity of 0.77 (adapted 0.86) and specificities between 0.70 and 1.00. The BSI-FASD subdomains differed in their power to differentiate FASD from the groups. This study established that the BSI-FASD is an efficient instrument to screen adults with suspected FASD. The BSI-FASD may facilitate future diagnostic evaluation and thereby contribute to improved treatment of affected individuals.
Identifiants
pubmed: 33664281
doi: 10.1038/s41598-021-83942-2
pii: 10.1038/s41598-021-83942-2
pmc: PMC7933170
doi:
Substances chimiques
Ethanol
3K9958V90M
Types de publication
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5233Références
Can J Psychiatry. 2019 Mar;64(3):161-163
pubmed: 30835512
Lancet. 1973 Jun 9;1(7815):1267-71
pubmed: 4126070
Eur Arch Psychiatry Clin Neurosci. 2019 Sep;269(6):681-687
pubmed: 30353263
J Popul Ther Clin Pharmacol. 2011;18(3):e494-9
pubmed: 22124027
Nervenarzt. 2004 Sep;75(9):888-95
pubmed: 15378249
Prog Neurobiol. 2019 Jan;172:84-103
pubmed: 29886148
Acta Psychiatr Scand. 2017 Jul;136(1):96-107
pubmed: 28383757
Alcohol Res. 2015;37(1):97-108
pubmed: 26259091
Nervenarzt. 2002 Sep;73(9):830-8
pubmed: 12215873
Addict Biol. 2020 Mar;25(2):e12866
pubmed: 31859437
Alcohol Alcohol. 2001 Mar-Apr;36(2):147-59
pubmed: 11259212
Nervenarzt. 2008 Mar;79(3):320-7
pubmed: 18210051
Lancet Neurol. 2019 Aug;18(8):760-770
pubmed: 31160204
Birth Defects Res C Embryo Today. 2016 Jun;108(2):174-80
pubmed: 27297122
CMAJ. 2016 Feb 16;188(3):191-197
pubmed: 26668194
Am J Med Genet C Semin Med Genet. 2007 Aug 15;145C(3):261-72
pubmed: 17640043
Alcohol Alcohol. 2019 Jan 9;54(5):545-550
pubmed: 31216355
Prog Neurobiol. 2012 Jan;96(1):136-63
pubmed: 22115850
JAMA Pediatr. 2017 Oct 1;171(10):948-956
pubmed: 28828483
Int J Soc Psychiatry. 2016 Mar;62(2):156-66
pubmed: 26619849
Pediatrics. 2015 Jan;135(1):e52-8
pubmed: 25535260
Eur J Health Econ. 2017 Jun;18(5):575-585
pubmed: 27279344